Latest News

  • Heidi Rehm Calls For Sharing of Variant Interpretation Data

    Diagnostics World | In an invited commentary published on Friday in Genetics in Medicine, Heidi Rehm outlines the state of variant interpretation, and makes a call to the community to share variant interpretation data. “I… put out a plea to the community to step up and take action to ensure transparency in variant interpretation, to allow laboratories to subject their interpretations to peer review by the community, and to enable aggregation of evidence to improve knowledge over time,” she writes.

    Jul 17, 2017
  • Teladoc Completes Acquisition Of Best Doctors

    Diagnostics World Brief | Teladoc today announced the completion of its acquisition of Best Doctors, the world’s leading expert medical consultation company focused on improving health outcomes for the most complex, critical, and costly medical issues.

    Jul 17, 2017
  • NHS Hospitals Could Get DNA Readers Within Five Years As Trials Begin

    The Telegraph | A trial for the identification and treatment of hospital-acquired pneumonia is starting in the UK. The trial will pit Oxford Nanopore's MinION reader against two other non-sequencing genetic tests. The goal is to accurately and quickly identify the bacteria causing pneumonia, so the right antibiotic can be prescribed.

    Jul 13, 2017
  • Metal-Free MRI Contrast Agent Could Be Safer For Some Patients

    MIT News | Researchers from MIT and the University of Nebraska have developed a metal-free MRI contrast agent that could be safer for certain patients. The compound contains organic molecules called nitroxides instead of metal and may be used to generate more informative MRI scans of tumors.

    Jul 13, 2017
  • Nestle invests in microbiome-based diagnostics venture

    Reuters | Food group Nestle's (NESN.S) health science business is investing 20 million euros ($22.8 million) in a joint venture with pharma and diagnostics company Enterome SA to develop microbiome-based diagnostics for inflammatory bowel and liver diseases, Enterome said on Tuesday.

    Jul 12, 2017
  • Precision Medicine Outside Of Oncology

    Diagnostics World Brief | Jonathan Pan of Aevi Genomic Medicine is featured on this podcast from Cambridge Health Tech Institute for the Next Generation Diagnostic Summit. Topics include precision medicine outside of oncology, unique genomic approaches, implementation in routine care, and more.

    Jul 11, 2017
  • Chemotherapy Before Breast Cancer Surgery Might Fuel Metastasis

    STAT | When breast cancer patients get chemotherapy before surgery, it can make remaining malignant cells spread to distant sites, a new study found.

    Jul 10, 2017
  • Walking Down Evidence Street: Where The Market Meets Evidence

    Diagnostics World Brief | Suzanne Belinson of Blue Cross Blue Shield Association is featured on this podcast from Cambridge Health Tech Institute for the Next Generation Diagnostic Summit. Topics include using web-based platform where stakeholders can view evidence, if we need more standardized requirements for payers and regulators, and hopes for the conference.

    Jul 5, 2017
  • Illumina Announces Companion Diagnostic For Amgen Colorectal Cancer Drug

    Diagnostics World Brief | Illumina has announced FDA approval of its Extended RAS Panel for use on the MiSeqDx System. The next-generation sequencing (NGS) kit is intended to help clinicians identify which patients are eligible for treatment of metastatic colorectal cancer with Amgen’s Vectibix (panitumumab).

    Jun 30, 2017
  • Quest Diagnostics, MDxHealth, QIAGEN, And More: News From June 2017

    Diagnostics World Brief | News, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Quest Diagnostics, MDxHealth, QIAGEN, and more.

    Jun 29, 2017
  • Genoptix And Bionano Genomics Announce Strategic Alliance

    Diagnostics World Brief | Genoptix and Bionano Genomics today announced an exclusive agreement to co-develop information-rich diagnostics for selected hematologic oncology indications in the US using Bionano’s Saphyr System.

    Jun 28, 2017
  • Quest Diagnostics, Walmart Partner To Offer Lab Testing Services In Stores

    Modern Healthcare | Walmart Stores and Quest Diagnostics announced a partnership Monday that will bring Quest's laboratory testing services to 15 Walmart locations in Florida and Texas by the end of the year.

    Jun 27, 2017
  • Reimbursement Of Companion Diagnostics: Discussions For Precision Medicine

    Diagnostics World Brief | Omar Perez of Pfizer is featured on this podcast from Cambridge Health Tech Institute for the Next Generation Diagnostic Summit. Topics include using key commercialization challenges for precision medicine or companion diagnostics, starting the discussion between a diagnostic and a pharmaceutical company regarding co-commercialization, and more.

    Jun 27, 2017
  • Emulate Awarded Grant To Fund Use Of Human Emulation System Aboard The International Space Station

    Diagnostics World Brief | Emulate announced that it has received a research grant to use the company’s human Brain-Chip system and develop a fully automated research platform, to conduct experiments on the International Space Station.

    Jun 22, 2017
  • Geisinger’s Strategy For Clinical NGS Implementation

    Diagnostics World Brief | Marc Williams of Geisinger Health System is featured on this podcast from Cambridge Health Tech Institute for the Next Generation Diagnostic Summit. Topics include implementation of NGS in routine car, challenges to overcome, and exciting applications of NGS.

    Jun 20, 2017
  • A Look Ahead To The Next Generation Dx Summit

    Diagnostics World | The Next Generation Dx Summit will take place August 15-18 in Washington, D. C. Featuring 12 different conference programs covering an array of topics from cancer immunotherapy to point-of-care testing, here are a few highlights for #NGDx17.

    Jun 19, 2017